EP Written Question on migraines tabled by Liam Aylward
Migraine in the European Union
On the 22nd of May Liam Aylward (ALDE, UK) tabled a EP Written Question on migraines. He asks about improvements to treatment and quality of life, promotion in investment into research, awareness to reduce costs and protection under employment and disability laws.
Questions for written answer E-005199/2012 to the Commission
Liam Aylward (ALDE Alliance for Liberals and Democrats Europe)
Migraine is a neurological brain disorder, classified by the World Health Organisation as the 19th leading cause of disability worldwide and the 12th leading cause of disability amongst women. According to the WHO, a person suffering from a severe migraine attack is as incapacitated as a patient suffering from quadriplegia, and more incapacitated than a blind person. Migraine can be a chronic, debilitating and disabling disease with significant associated socio-economic effects, such as absenteeism and social exclusion: its overall cost to Europe is some EUR 43.5 billion.
- What measures is the Commission taking to promote resources and services that improve the treatment and quality of life of those affected by migraine?
- Does the Commission plan to make further funding available to promote investment in research into the causes of migraine and headache, and the development of new medications?
- Medication overuse for headache disorders costs on average EUR 2 291 per person affected each year. Does the Commission plan to make funding available for the promotion of awareness of this problem, so that such costs can be reduced?
- Can the Commission clarify whether it plans to recognise migraine as a disability and ensure that those affected receive equal protection under national and European disability and employment laws?
Please find here the original message.